首页> 美国卫生研究院文献>other >Luciferase-based reporter to monitor the transcriptional activity of the SIRT3 promoter
【2h】

Luciferase-based reporter to monitor the transcriptional activity of the SIRT3 promoter

机译:基于萤光素酶的报告基因可监测SIRT3启动子的转录活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Sirtuin 3 (SIRT3) is a major regulator of oncometabolism. Its activity or lack thereof significantly affects cellular oxidative stress, glycolytic gene expression, and tumorigenic potential. Thus, a system to accurately measure the level of SIRT3 transcriptional activation could lead to the identification of new cancer therapies and may have diagnostic applications. Here, we describe the development of a luciferase-based plasmid reporter system to measure activation of the human SIRT3 promoter. We detail the steps involved in construction of the system, including primer design, promoter fragment amplification, cloning, bacterial transformation, and mutagenesis. We validate this system in human 293T cells using the known activation of the SIRT3 promoter by the transcription factor estrogen-related receptor α, and we further show novel activation by the small molecule rapamycin, which has been used as a calorie restriction mimetic. Finally, we give an overview of the complementary molecular biology techniques that may be used to verify the results of this system.
机译:Sirtuin 3(SIRT3)是肿瘤代谢的主要调节剂。它的活性或缺乏活性会严重影响细胞的氧化应激,糖酵解基因表达和致瘤潜力。因此,准确测量SIRT3转录激活水平的系统可能导致鉴定新的癌症疗法,并且可能具有诊断应用。在这里,我们描述了基于荧光素酶的质粒报告系统的发展,以测量人类SIRT3启动子的激活。我们详细介绍了系统构建所涉及的步骤,包括引物设计,启动子片段扩增,克隆,细菌转化和诱变。我们使用已知的转录因子雌激素相关受体α激活SIRT3启动子,在人293T细胞中验证了该系统,并进一步显示了小分子雷帕霉素的新激活作用,该小分子雷帕霉素已被用作卡路里限制模拟物。最后,我们概述了可用于验证该系统结果的互补分子生物学技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号